NCT01146067View on ClinicalTrials.gov

Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Healthy
Interventions
DRUG

Rivastigmine

Rivastigmine capsules 1.5 mg

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY